Status:

COMPLETED

Magnetocardiography as a Non-Invasive Tool for Detecting Tissue Rejection in Heart Transplant Patients

Lead Sponsor:

Mayo Clinic

Collaborating Sponsors:

CardioMag Imaging

Conditions:

Heart Transplantation

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

Heart transplantation is a great procedure for selected patients with end-stage heart failure, but graft rejection remains a major factor limiting long-term survival despite continued advancement in t...

Detailed Description

Heart transplantation is an advantageous procedure for selected patients with end-stage heart failure. Graft rejection remains a major factor limiting long-term survival despite continued advancement ...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Adult heart transplant recipients referred for surveillance biopsies
  • Age greater than 18 years old

Exclusion

    Key Trial Info

    Start Date :

    December 1 2004

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    January 1 2007

    Estimated Enrollment :

    6 Patients enrolled

    Trial Details

    Trial ID

    NCT00169936

    Start Date

    December 1 2004

    End Date

    January 1 2007

    Last Update

    January 28 2010

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Mayo Clinic

    Rochester, Minnesota, United States, 55905

    Magnetocardiography as a Non-Invasive Tool for Detecting Tissue Rejection in Heart Transplant Patients | DecenTrialz